"Preemptive Pan-Genotypic Direct Acting Antiviral Therapy in Donor HCV-Positive to Recipient HCV- Negative Cardiac Transplantation Produces Viral Clearance and is Associated with Favorable Outcomes" by G D Lewis

Presentation

Preemptive Pan-Genotypic Direct Acting Antiviral Therapy in Donor HCV-Positive to Recipient HCV- Negative Cardiac Transplantation Produces Viral Clearance and is Associated with Favorable Outcomes

39th ISHLT Annual Scientific Meeting (2019)

G D Lewis
E D Bethea
K Gaj
J Gustafson
A Dugal
K Turvey
E Coglianese
S S Thomas
C Newton-Cheh
N E Ibrahim
W D Carlson
R V Shah
J E Ho
M Nayor
J K Steiner
Maxwell E Afari, MaineHealth
T Lebeis
J C Madsen
M A Villavicencio-Theoduloz
R T Chung
D A D'Alessandro

Keywords

Antiviral Agents,
Hepatitis C,
Chronic,
Tissue Donors,
Genotype,
Heart Transplantation

Disciplines

Cardiology and
Surgery

Publication Date

April, 2019

Location

Orlando, FL

Citation Information

G D Lewis, E D Bethea, K Gaj, J Gustafson, et al.. "Preemptive Pan-Genotypic Direct Acting Antiviral Therapy in Donor HCV-Positive to Recipient HCV- Negative Cardiac Transplantation Produces Viral Clearance and is Associated with Favorable Outcomes" 39th ISHLT Annual Scientific Meeting (2019)
Available at: http://works.bepress.com/maxwell-afari/10/